Skip to main content
Clinical Trials/NCT01512212
NCT01512212UnknownNot Applicable

New Thyroid Fine Needle Biopsy Apparatus

SB Istanbul Education and Research Hospital2 sites in 1 country40 target enrollmentStarted: January 1, 2012Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
40
Locations
2
Primary Endpoint
number of cells

Study Overview

Brief Summary

Evaluation of the effectivity of the new thyroid fine needle aspiration biopsy (FNAB) apparatus of which patented from Turkish Patent Institute.

Detailed Description

The author group of this investigation produced a new thyroid fine needle aspiration biopsy (FNAB) apparatus and patented it from Turkish patent Institute. FNAB indicated nodular goitre patients are the subjects of this research. First, the investigators will perform standart FNAB after this procedure will perform FNAB with new apparatus. The investigators will evaluate the aspirates according to number of cells and malignity ratio of cells.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
Single (Investigator)

Eligibility Criteria

Ages
17 Years to 85 Years (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • fine needle aspiration biopsy indicated noduler goiter patients

Exclusion Criteria

  • diffuse goiter

Outcomes

Primary Outcomes

number of cells

Time Frame: 2

number of aspirated cells will be compared

Secondary Outcomes

  • type of cells(2)

Investigators

Sponsor
SB Istanbul Education and Research Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Erhan Aysan

MD Prof.

SB Istanbul Education and Research Hospital

Study Sites (2)

Loading locations...

Similar Trials